At the molecular level, a study shows that the Akt signalling pathway suppresses cell migration and invasion through FOXO1 to inhibit runt-related transcription factor 2 (RUNX2) transcriptional activity in prostate cancer [106]. The gene discussed is AKT1; the disease is prostate cancer.